The Technical Analyst
Select Language :
CNS Pharmaceuticals Inc [CNSP]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

CNS Pharmaceuticals Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

CNS Pharmaceuticals Inc is listed at the  Exchange

0.33% $0.370

America/New_York / 28 mar 2024 @ 12:16


CNS Pharmaceuticals Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3.12 mill
EPS: -7.60
P/E: -0.0500
Earnings Date: Mar 31, 2024
SharesOutstanding: 8.43 mill
Avg Daily Volume: 0.410 mill
RATING 2024-03-27
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0500 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.01x
Company: PE -0.0500 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.311 - 0.427

( +/- 15.72%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-01 Mahery Amy Buy 12 420 Option to purchase common stock
2024-02-01 Gumulka Jerzy Buy 33 333 Series B Warrant to purchase common stock
2024-02-01 Gumulka Jerzy Buy 33 333 Series A Warrant to purchase common stock
2024-02-01 Gumulka Jerzy Buy 33 333 Common stock
2024-02-01 Evans Carl Anthony Buy 33 333 Series B Warrant to purchase common stock
INSIDER POWER
93.51
Last 86 transactions
Buy: 3 691 286 | Sell: 2 431 436

Forecast: 13:55 - $0.370

Live Trading Signals (every 1 min)

Forecast 1: 12:25 - $0.366
Forecast 2: 13:15 - $0.368
Forecast 3: 13:55 - $0.370
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.370 (0.33% )
Volume 0.0987 mill
Avg. Vol. 0.410 mill
% of Avg. Vol 24.06 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for CNS Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for CNS Pharmaceuticals Inc

RSI

Intraday RSI14 chart for CNS Pharmaceuticals Inc

Last 10 Buy & Sell Signals For CNSP

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            CNS Pharmaceuticals Inc

CNSP

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

Last 10 Buy Signals

Date Signal @
HNTUSDMar 28 - 12:15$6.10
CBKUSDMar 28 - 12:131.096
AMKTUSDMar 28 - 12:14221.00
BURGERUSDMar 28 - 12:140.883
DEGOUSDMar 28 - 12:143.67
WBETHUSDMar 28 - 12:103 679.57
WAVESUSDMar 28 - 12:13$3.87
SFUNDUSDMar 28 - 12:13$4.28
STETHUSDMar 28 - 12:133 552.78
SSVUSDMar 28 - 12:1459.02

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.